Seeing Angiogenesis: Multiparametric Ultrasound as a Non-Invasive Window into the Vascularization Status of Cervical...

Cervical lymph node status is the single most important prognostic determinant in head and neck squamous cell carcinoma (HNSCC), yet conventional gray-scale ultrasound relies on morphological criteria that only indirectly reflect the underlying biological process driving nodal progression: tumor angiogenesis. This narrative review focuses specifically on cervical lymph nodes and examines whether multiparametric ultrasound (B-mode, Doppler, elastography, and contrast-enhanced ultrasound [CEUS]) can serve as a non-invasive, repeatable surrogate for nodal angiogenic activity in HNSCC and outlines a practical framework for its use in the head and neck clinic; evidence on the primary tumor itself was outside this review's scope. A narrative synthesis of the literature on angiogenesis biology in HNSCC and on multiparametric ultrasound of cervical lymph nodes was performed, drawing on systematic reviews, meta-analyses, and clinical pilot studies identified through PubMed-indexed sources. Vascular endothelial growth factor (VEGF)-driven neoangiogenesis is a recognized diagnostic, prognostic, and predictive biological axis in HNSCC. Ultrasound modalities that visualize or quantify microvascular architecture and perfusion-Doppler vascularity patterns, shear-wave elastography, and CEUS-track features that are biologically continuous with angiogenesis (disorganized, high-permeability neovessels; altered tissue stiffness from stromal remodeling). Combining CEUS with B-mode ultrasound improves diagnostic accuracy for inconclusive cervical lymph nodes compared with either modality alone, and pilot multiparametric protocols in HNSCC show reproducible irregular contrast enhancement and elastographic heterogeneity in metastatic nodes. Multiparametric ultrasound does not replace histology, but it offers a repeatable, radiation-free, low-cost window onto the vascular phenotype of HNSCC that complements morphological staging. Given the heterogeneity and methodological limitations of the available evidence, multiparametric ultrasound should currently be regarded as a promising imaging biomarker rather than an established non-invasive surrogate for angiogenesis. Larger prospective, HNSCC-specific cohorts using standardized acquisition protocols, with direct histological correlation, are needed before this approach can be adopted into routine diagnostic pathways.